Tag: Surrogate endpoint in clinical trial

USFDA withdraws approval of drug Makena, Pharmaceutical company failed to submitte post market study, to evaluate saftey and to confirm the efficacy to FDA. USFDA withdraws approval of drug Makena, the drug approved under accelerated approval pathway. The drug Makena is now no longer an approved drug, the drug was used for treatment as a…